GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Cyclically Adjusted FCF per Share

Theriva Biologics (FRA:SFY) Cyclically Adjusted FCF per Share : €-50.65 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Theriva Biologics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Theriva Biologics's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.262. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-50.65 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 5.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Theriva Biologics was 45.10% per year. The lowest was -4.80% per year. And the median was 4.60% per year.

As of today (2024-05-31), Theriva Biologics's current stock price is €0.236. Theriva Biologics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-50.65. Theriva Biologics's Cyclically Adjusted Price-to-FCF of today is .


Theriva Biologics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Theriva Biologics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics Cyclically Adjusted FCF per Share Chart

Theriva Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -62.27 -45.92 -58.46 -59.04 -53.13

Theriva Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.74 -52.84 -52.58 -53.13 -50.65

Competitive Comparison of Theriva Biologics's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Theriva Biologics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theriva Biologics's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theriva Biologics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Theriva Biologics's Cyclically Adjusted Price-to-FCF falls into.



Theriva Biologics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Theriva Biologics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.262/131.7762*131.7762
=-0.262

Current CPI (Mar. 2024) = 131.7762.

Theriva Biologics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -14.599 100.560 -19.131
201409 -21.174 100.428 -27.783
201412 -18.654 99.070 -24.812
201503 -24.327 99.621 -32.179
201506 -31.240 100.684 -40.887
201509 -55.628 100.392 -73.019
201512 -38.885 99.792 -51.348
201603 -19.750 100.470 -25.904
201606 -19.463 101.688 -25.222
201609 -20.950 101.861 -27.103
201612 -30.433 101.863 -39.370
201703 -16.747 102.862 -21.454
201706 -14.556 103.349 -18.560
201709 -10.796 104.136 -13.662
201712 -9.063 104.011 -11.482
201803 -13.433 105.290 -16.812
201806 -10.022 106.317 -12.422
201809 -7.660 106.507 -9.477
201812 -1.868 105.998 -2.322
201903 -2.387 107.251 -2.933
201906 -1.602 108.070 -1.953
201909 -1.654 108.329 -2.012
201912 -1.930 108.420 -2.346
202003 -2.627 108.902 -3.179
202006 -0.977 108.767 -1.184
202009 -0.897 109.815 -1.076
202012 -1.218 109.897 -1.460
202103 -0.309 111.754 -0.364
202106 -0.163 114.631 -0.187
202109 -0.139 115.734 -0.158
202112 -0.322 117.630 -0.361
202203 -0.322 121.301 -0.350
202206 -0.260 125.017 -0.274
202209 -0.284 125.227 -0.299
202212 -0.321 125.222 -0.338
202303 -0.347 127.348 -0.359
202306 -0.237 128.729 -0.243
202309 -0.169 129.860 -0.171
202312 -0.354 129.419 -0.360
202403 -0.262 131.776 -0.262

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Theriva Biologics  (FRA:SFY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Theriva Biologics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Theriva Biologics (FRA:SFY) Business Description

Industry
Traded in Other Exchanges
Address
9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-25-2022